get breaking glp-1
email updates

OTP Exclusive Interview: OFA Legal Counsel Talks Future of Compound Tirzepatide

Leptin and GLP-1: The Next (old) Frontier in Obesity Treatment?

Telehealth and Obesity Care: New Data Shows the Power of Combining GLP-1 Medications with Virtual Platforms

Novo Nordisk Eyes Manufacturing Edge with Single-Chamber CagriSema in New Phase 1 Trial

APC Pushes Back Against Novo Nordisk’s Bid to Limit Compounded Semaglutide

Medicare + Medicaid to Cover Zepbound? Here’s Why It’s Not as Simple as It Sounds!